Advertisement
Screener

Hemab Therapeutics Holdings, Inc. (COAG) Customer Breakdown

Hemab Therapeutics Holdings, Inc. Customer Breakdown

Customer relationships and concentrations across all retained periods. Named customers and their revenue are shown when disclosed. Anonymous customers, customer groups and sales channels are labelled separately. Receivable concentration measures unpaid balances, not revenue contribution. A biggest customer by revenue can be identified only from disclosed customer revenue. Missing names and amounts remain missing; identities are not assumed to match between periods.

Period / as ofCustomer / groupCategoryCustomer revenueShare of revenueShare of trade receivablesBasis and limitations

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunocore Holdings plc (IMCR)$1.613B-90.43
NOVAVAX INC (NVAX)United States$1.748B-6.26
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Vericel Corp (VCEL)United States$2.011B93.97
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16